Cross-linking agent, gel intermediate and use thereof

By crosslinking with sodium hyaluronate with disulfide bonds and using glutathione treatment, the problem of insufficient adhesion of sodium hyaluronate gel for injection was solved, and the gel was realized Strong adhesion and biocompatibility simplify the process flow and are suitable for industrial production.

CN115926211BActive Publication Date: 2024-11-12BLOOMAGE BIOTECHNOLOGY CORP LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310072647.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-01-12
Publication Date
2024-11-12
Estimated Expiration
2041-01-12

AI Technical Summary

Technical Problem

The existing sodium hyaluronate gel for injection is insufficient in vivo, easy to displace, and the post-treatment process is complicated, which is not conducive to industrial production.

Method used

The epoxy crosslinking agent A containing disulfide bonds is crosslinked with sodium hyaluronate, and treated with glutathione to control the reaction conditions and substance ratio to form a sodium hyaluronate gel with good adhesion. Dialysis removes substances that are not involved in the reaction and simplifies the process flow.

Benefits of technology

The obtained gel has strong tissue adhesion, prevents displacement, has good biocompatibility, simple process and short dialysis time, making it suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004065163770000031
    Figure BDA0004065163770000031
  • Figure BDA0004065163770000041
    Figure BDA0004065163770000041
  • Figure BDA0004065163770000042
    Figure BDA0004065163770000042
Patent Text Reader

Abstract

The present application discloses a cross-linking agent and its use in preparing an adhesive sodium hyaluronate gel for injection, and also discloses a gel intermediate and its use in preparing an adhesive sodium hyaluronate gel for injection. The process for preparing an adhesive sodium hyaluronate gel for injection using the cross-linking agent and gel intermediate of the present application is simple, the dialysis time is short, the energy consumption is low, and no by-products are produced. The adhesive sodium hyaluronate gel for injection prepared using the cross-linking agent and gel intermediate of the present application has good mechanical properties, is easy to inject, has strong binding force with tissues, does not cause obvious displacement in tissues, and has good biocompatibility.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This case is a divisional application of the application filed on January 12, 2021, entitled "An Injectable Adhesive Sodium Hyaluronate Gel and Its Preparation Method Thereof", with application number CN202110038748.0. Technical Field

[0002] This application belongs to the field of cross-linked hyaluronic acid technology. Specifically, it relates to a cross-linking agent and its uses, and a gel intermediate and its uses. Background Technology

[0003] Hyaluronic acid is a natural high-molecular-weight polysaccharide and a component of the extracellular matrix. It boasts excellent biocompatibility and moisturizing properties, earning it the title of a superior natural moisturizing factor. It has been widely used in fields such as aesthetic medicine, tissue engineering, regenerative medicine, and medical devices. Currently, injectable sodium hyaluronate gels are mostly based on BDDE as a cross-linking agent. The BDDE cross-linking process is simple, suitable for industrial production, and its in vivo metabolic pathway is clear and safe, thus making it widely adopted.

[0004] Currently used injectable sodium hyaluronate gels are mainly cross-linked gels obtained by using BDDE as a cross-linking agent and sodium hyaluronate as a raw material. They do not interact with tissues in the body and do not form a tight bond with tissues. At the same time, when injected into easily movable areas such as the lips and corners of the eyes, the mechanical force will damage the gel structure. Under the action of force, the gel will slip and transfer to areas in the tissue that are not easily stressed, affecting the filling and cosmetic functions of the injectable gel for specific areas.

[0005] In existing technologies, Krum Kafedjiiski et al.'s paper, "Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery," discloses a cross-linked product of hyaluronic acid and cysteine ​​ethyl ester. In the presence of activators EDAC and NHS, HA and cysteine ​​ethyl ester amide bonds are covalently grafted to form HA-Cys, which has a high thiol content, resulting in strong gel adhesion. Further cross-linking under oxygen conditions forms an adhesive hyaluronic acid gel. However, this reaction requires prolonged dialysis to remove the activator and unreacted cysteine ​​ethyl ester during post-processing, making the reaction process complex and unsuitable for injection filling. Summary of the Invention

[0006] To address the issue of weak affinity between injectable sodium hyaluronate gel and tissues, this application provides a crosslinking agent and gel intermediate for preparing injectable adhesive sodium hyaluronate gel. The sodium hyaluronate gel prepared by this application not only has good viscoelasticity but also excellent tissue adhesion, effectively preventing displacement after injection into the body. Furthermore, the injectable sodium hyaluronate gel prepared by this application maintains good biocompatibility.

[0007] The specific technical solution of this application is as follows:

[0008] 1. A method for preparing an injectable adhesive sodium hyaluronate gel, characterized in that it comprises the following steps:

[0009] Synthesizing crosslinking agent A: Synthesizing crosslinking agent A containing disulfide bonds;

[0010] Crosslinking: Sodium hyaluronate is reacted with crosslinking agent A and crosslinking agent B to obtain gel L;

[0011] Preparation of gel M: Gel M was obtained by treating gel L with glutathione;

[0012] Processing gel M: Dialyze gel M to obtain the injectable adhesive sodium hyaluronate gel.

[0013] 2. The preparation method according to item 1, characterized in that, in the step of synthesizing crosslinking agent A, cystine and 1,4-butanediol diglycidyl ether are used as raw materials, reacted under alkaline conditions to generate a product with the following structural formula: Crosslinking agent A;

[0014] Preferably, in the step of synthesizing crosslinking agent A, the molar ratio of cystine to 1,4-butanediol diglycidyl ether is 1:2 to 3, preferably 1:2.3;

[0015] Preferably, in the step of synthesizing crosslinking agent A, the synthesis temperature of crosslinking agent A is 10-30°C.

[0016] 3. The preparation method according to item 1 or 2, characterized in that, in the crosslinking step, the molar ratio of the crosslinking agent A to the sodium hyaluronate repeating unit is 0.03 to 0.075:1.

[0017] 4. The preparation method according to any one of items 1 to 3, characterized in that, in the crosslinking step, the crosslinking agent B is 1,4-butanediol diglycidyl ether or an ethylene glycol-like compound.

[0018] Preferably, in the crosslinking step, the molar ratio of the crosslinking agent B to the sodium hyaluronate repeating unit is 0.03 to 0.075:1;

[0019] Preferably, in the crosslinking step, the molar ratio of crosslinking agent A to crosslinking agent B is 0.5 to 1:1.

[0020] 5. The preparation method according to any one of items 1 to 4, characterized in that, in the crosslinking step, the sodium hyaluronate is reacted with the crosslinking agent A and the crosslinking agent B under conditions of pH > 9 to obtain the gel L;

[0021] Preferably, in the crosslinking step, the molecular weight of the sodium hyaluronate is 300-800 kDa.

[0022] 6. The preparation method according to any one of items 1 to 5, characterized in that, in the step of preparing gel M, the concentration of glutathione is 10 to 30 mmol / L.

[0023] 7. The preparation method according to any one of items 1 to 6, characterized in that, in the step of preparing gel M, gel L is dialyzed in an alkaline or neutral buffer containing glutathione to obtain gel M;

[0024] Preferably, in the step of processing gel M, gel M is dialyzed in a buffer solution with a pH of 7.2 to 7.7 to obtain the injectable adhesive sodium hyaluronate gel.

[0025] Preferably, in the gel treatment step M, the dialysis time is 6–72 h.

[0026] 8. The preparation method according to any one of items 1 to 7, characterized in that, in the step of processing gel M, the gel M is dialyzed, and then an anesthetic, preferably an ester or amide local anesthetic, is added to obtain the injectable adhesive sodium hyaluronate gel.

[0027] 9. An injectable adhesive sodium hyaluronate gel, characterized in that it comprises a compound having the structure shown in formula (I);

[0028]

[0029] Preferably, a is 4 to 1117, b is 4 to 1117, and c is 65 to 5211;

[0030] More preferably, a is 44–298, b is 45–298, and c is 655–1390.

[0031] 10. The sodium hyaluronate gel according to item 9, characterized in that it is prepared by any one of items 1 to 8.

[0032] 11. A crosslinking agent, characterized in that its structural formula is as follows:

[0033] 12. Use of the crosslinking agent described in item 11 in the preparation of injectable adhesive sodium hyaluronate gel.

[0034] 13. A gel intermediate, characterized in that it comprises a compound having the structure shown in the following formula:

[0035] 14. The gel intermediate according to item 13, characterized in that a is 4 to 1117, b is 4 to 1117, and c is 65 to 5211.

[0036] 15. The gel intermediate according to item 14, characterized in that a is 44-298, b is 45-298, and c is 655-1390.

[0037] 16. Use of the gel intermediate described in any one of items 13 to 15 in the preparation of injectable adhesive sodium hyaluronate gel.

[0038] The effects of the invention

[0039] This application employs an epoxy crosslinking agent A containing disulfide bonds and 1,4-butanediol diglycidyl ether or an ethylene glycol-like compound. Cross-linking with sodium hyaluronate, followed by treatment with glutathione, and further defining the molar ratio of each reactant, yields an injectable adhesive sodium hyaluronate gel. This gel exhibits good mechanical properties, is easy to inject, has strong tissue adhesion, does not cause significant intra-tissue displacement, and demonstrates good biocompatibility. The preparation process described in this application is simple, requires short dialysis time, consumes little energy, produces no byproducts, is pollution-free, and is easily industrialized. Attached Figure Description

[0040] Figure 1 This is a schematic diagram of the adhesiveness test method for injectable adhesive sodium hyaluronate gel of this application. Detailed Implementation

[0041] The specific embodiments of this application will be described in more detail below. It should be noted that the terms "comprising" or "including" used throughout the specification and claims are open-ended and should be interpreted as "comprising but not limited to". The following descriptions of preferred embodiments of this application are for the purpose of implementing the general principles of the specification and are not intended to limit the scope of this application. The scope of protection of this application shall be determined by the appended claims.

[0042] On the one hand, this application provides a crosslinking agent, characterized in that its structural formula is as follows:

[0043] In one specific embodiment, the crosslinking agent is synthesized via the following steps: using cystine and 1,4-Butanediol diglycidyl ether Using [a specific ingredient] as a raw material, a ring-opening reaction of an epoxide occurs under alkaline conditions to produce a product with the following structural formula: Crosslinking agent.

[0044] On the other hand, this application also provides the use of the above-mentioned crosslinking agent in the preparation of injectable adhesive sodium hyaluronate gel.

[0045] On one hand, this application provides a gel intermediate, characterized in that it comprises a compound having the structure shown in the following formula:

[0046]

[0047] In one specific embodiment, in the gel intermediate, a is selected from 4 to 1117, for example, it can be 4, 10, 44, 50, 100, 200, 250, 298, 300, 400, 500, 600, 700, 800, 900, 1000, 1110, 1117, etc.; b is selected from 4 to 1117, for example, it can be 4, 10, 44, 50, 100, 200, 250, 298, 300, 400, 500, 600, 700, 800, 900, 1000, 1110, 1117, etc.; c is selected from 65 to 5211, for example, it can be 65, 100, 300, 600, 655, 1000, 1390, 2000, 3000, 4000, 5000, 5211, etc.

[0048] In one specific embodiment, in the gel intermediate, a is selected from 44 to 298, b is selected from 44 to 298, and c is selected from 655 to 1390.

[0049] In one specific embodiment, the gel intermediate is synthesized via the following steps: sodium hyaluronate is reacted with the structure having the following formula. Crosslinking agents and 1,4-butanediol diglycidyl ether or ethylene glycol-like compounds The reaction is carried out to obtain the gel intermediate, and n can be, for example, 1, 2, 3, 4, 5, 6, 7, 8, 10, 15, 20, 25, 30, 35, 40, 45, etc.

[0050] In another aspect, this application also provides the use of any of the aforementioned gel intermediates in the preparation of injectable adhesive sodium hyaluronate gel.

[0051] On one hand, this application provides a method for preparing injectable adhesive sodium hyaluronate gel, characterized by comprising the following steps:

[0052] Synthesizing crosslinking agent A: Synthesizing crosslinking agent A containing disulfide bonds;

[0053] Crosslinking: Sodium hyaluronate is reacted with crosslinking agent A and crosslinking agent B to obtain gel L;

[0054] Preparation of gel M: Gel M was obtained by treating gel L with glutathione;

[0055] Processing gel M: Dialyze gel M to obtain the injectable adhesive sodium hyaluronate gel.

[0056] The "glutathione" (GSH) in this application is a tripeptide containing a γ-amide bond and a thiol group, composed of glutamic acid, cysteine, and glycine, and is present in almost every cell of the body. Glutathione helps maintain normal immune system function and has antioxidant and detoxification effects. The thiol group on cysteine ​​is its active group, which can undergo a redox reaction with disulfide bonds, reducing the disulfide bonds to free thiol groups and forming oxidized glutathione.

[0057] In this application, "dialysis" refers to a separation and purification technique that removes cross-linking agents that have not reacted with hyaluronic acid by diffusing small molecules through the gel bulk into water (or buffer solution).

[0058] In this application, "adhesion" refers to the gel's affinity for tissues, such as... Figure 1 As shown, the method involves fixing fresh pigskin onto a glass slide with the inside of the pigskin containing subcutaneous tissue facing outwards. Then, a finished gel is evenly applied to the inner tissue of the pigskin. Two glass slides loaded with gel are overlapped and left to stand for a period of time. A weight is then applied, and a stopwatch is used to time the time it takes for the two glass slides to completely separate. The separation time is used to characterize the adhesion.

[0059] The preparation method of this application first synthesizes a crosslinking agent A, and then uses crosslinking agent A and crosslinking agent B to carry out a crosslinking reaction with sodium hyaluronate. By controlling the proportion of raw materials in each reaction step, the degree of crosslinking of the final injectable adhesive sodium hyaluronate gel can be determined while ensuring the adhesiveness of the injectable adhesive sodium hyaluronate gel. This effectively prevents displacement after injection into the body and has good biocompatibility. The preparation method of this application for adhesive sodium hyaluronate gel can impart adhesive properties to the gel without the need for long-term dialysis to remove activators and unreacted substances, and there are no by-products. The reaction process is simple, the dialysis time is short, and the preparation process time is short, which is conducive to industrial production. The prior art uses cysteine ​​to modify hyaluronic acid. This process requires a large amount of activator, which needs to be removed in the post-processing. The required dialysis time is long, and it cannot guarantee that thiol groups will be introduced into the sodium hyaluronate gel to impart adhesive properties. The crosslinking agent A synthesized in this application has the same reaction mechanism with hyaluronic acid as 1,4-butanediol diglycidyl ether, both involving ring-opening reactions between epoxy groups and active hydroxyl groups in hyaluronic acid. Therefore, the synthesis steps are simple, efficient, and yield the product.

[0060] In one specific embodiment, in the preparation method of this application, in the step of synthesizing crosslinking agent A, cystine is used. and 1,4-Butanediol diglycidyl ether Using [a specific ingredient] as a raw material, a ring-opening reaction of an epoxide occurs under alkaline conditions to produce a product with the following structural formula: Crosslinking agent A; in the crosslinking step, crosslinking agent B is 1,4-butanediol diglycidyl ether or an ethylene glycol-like compound. n can be, for example, 1, 2, 3, 4, 5, 6, 7, 8, 10, 15, 20, 25, 30, 35, 40, 45, etc.

[0061] The synthetic route for crosslinking agent A is shown below:

[0062]

[0063] The synthetic routes for gels L and M are shown below. The adhesive sodium hyaluronate gel of this application is obtained by the following synthetic route:

[0064]

[0065] In this application, "cystine" is an amino acid containing a disulfide bond, which can undergo redox reactions with reducing agents such as glutathione to form free sulfhydryl groups.

[0066] The “1,4-butanediol diglycidyl ether” (BDDE) in this application is an epoxy resin containing a 1,4-butanediether chain. It is a water-soluble epoxy resin, a yellow transparent liquid with an epoxy value of 0.63 to 0.74 and a viscosity of 15 to 20 mPa·s. It is prepared by polycondensation of 1,4-butanediol and epichlorohydrin.

[0067] In this specific embodiment, the content of thiol groups in the final injectable adhesive sodium hyaluronate gel can be controlled through crosslinking and the preparation of gel M, ensuring that the adhesiveness of the gel required for application is achieved.

[0068] In one specific embodiment, in the preparation method of this application, in the step of synthesizing crosslinking agent A, the molar ratio of cystine to 1,4-butanediol diglycidyl ether is 1:2 to 3, for example, it can be 1:2, 1:2.1, 1:2.2, 1:2.3, 1:2.5, 1:2.7, 1:2.9, 1:3, etc., preferably 1:2.3. Controlling the molar ratio of cystine to 1,4-butanediol diglycidyl ether within the above range results in crosslinking agent A with high purity.

[0069] In one specific embodiment, in the preparation method of this application, the synthesis temperature of the crosslinking agent A in the step of synthesis is 10-30℃, for example, it can be 10℃, 12℃, 14℃, 16℃, 18℃, 20℃, 22℃, 24℃, 26℃, 28℃, 30℃, etc.

[0070] In one specific embodiment, in the preparation method of this application, the molar ratio of the crosslinking agent A to the sodium hyaluronate repeating unit in the crosslinking step is 0.03 to 0.075:1, for example, it can be 0.03:1, 0.035:1, 0.04:1, 0.045:1, 0.05:1, 0.055:1, 0.06:1, 0.065:1, 0.07:1, 0.075:1, etc.

[0071] The “sodium hyaluronate repeating unit” in this application refers to the disaccharide repeating unit in sodium hyaluronate composed of D-glucuronic acid and N-acetylglucosamine.

[0072] In one specific embodiment, in the preparation method of this application, the molar ratio of the crosslinking agent B to the sodium hyaluronate repeating unit in the crosslinking step is 0.03 to 0.075:1, for example, it can be 0.03:1, 0.035:1, 0.04:1, 0.045:1, 0.05:1, 0.055:1, 0.06:1, 0.065:1, 0.07:1, 0.075:1, etc.;

[0073] In one specific embodiment, in the preparation method of this application, the molar ratio of the crosslinking agent A to the crosslinking agent B is 0.5 to 1:1, for example, it can be 0.5:1, 0.55:1, 0.6:1, 0.65:1, 0.7:1, 0.75:1, 0.8:1, 0.85:1, 0.9:1, 0.95:1, 1:1, etc.

[0074] In one specific embodiment, in the preparation method of this application, the crosslinking step involves reacting sodium hyaluronate with crosslinking agent A and crosslinking agent B under conditions of pH > 9 (e.g., 9.1, 9.5, 10, 10.5, 11, 11.5, 12, 12.5, 13, 13.5, 14, etc.) to obtain gel L. The molecular weight of the sodium hyaluronate is 300–800 kDa, for example, 300 kDa, 350 kDa, 400 kDa, 500 kDa, 700 kDa, 800 kDa, etc. If the molecular weight of the hyaluronic acid is too low, the mechanical strength of the gel formed after crosslinking is low, and it cannot play a filling role; if the molecular weight is too high, the mechanical strength of the gel formed after crosslinking is high, but its viscosity is also high, making it difficult to inject. Therefore, this invention selects hyaluronic acid within the above-mentioned range.

[0075] In one specific embodiment, in the preparation method of this application, during the crosslinking step, sodium hyaluronate is dissolved in a 1.0%–1.5% (w / w) NaOH solution to obtain a sodium hyaluronate solution. Crosslinking agent A and crosslinking agent B are mixed and added to the sodium hyaluronate solution. A crosslinking reaction is then carried out at 25–55°C for 7–9 hours to obtain gel L. In another specific embodiment, after the crosslinking step and before the gel M preparation step, the preparation method of this application further includes a crushing step: the gel L is mechanically crushed and sieved to obtain particulate gel A; in the gel M preparation step, glutathione is used to treat the particulate gel A to obtain gel M.

[0076] In one specific embodiment, in the preparation method of this application, in the step of preparing gel M, gel L is dialyzed in an alkaline or neutral buffer solution containing glutathione to obtain gel M. Glutathione can reduce the disulfide bonds in crosslinking agent A to thiol groups, making the final gel adhesive. Specifically, gel L is transferred to a container with mesh walls and a side cover, a certain amount of buffer solution containing glutathione is added, and the mixture is stirred at low speed for 6-8 hours. Then, the side cover is opened, the dialysate flows out through the mesh, and gel L is retained in the container. Fresh buffer solution is added again for dialyzing. The entire dialyzing process lasts for 6-72 hours. The concentration of glutathione is 10-30 mmol, for example, 10 mmol, 13 mmol, 15 mmol, 17 mmol, 20 mmol, 23 mmol, 25 mmol, 27 mmol, 30 mmol, etc., preferably 15 mmol. In this specific embodiment, the buffer solution can be phosphate buffer, etc.

[0077] In one specific embodiment, in the preparation method of this application, the step of processing gel M involves dialyzing gel M in a buffer solution with a pH of 7.2 to 7.7 to obtain the injectable adhesive sodium hyaluronate gel. The pH can be, for example, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7, etc., preferably 7.4.

[0078] In one specific embodiment, in the preparation method of this application, in the step of preparing gel M, the dialysis time is 6 to 72 hours, for example, 6 hours, 12 hours, 24 hours, 48 ​​hours, 60 hours, 72 hours, etc., preferably 24 to 48 hours; in the step of processing gel M, the dialysis time is 6 to 72 hours, for example, 6 hours, 12 hours, 24 hours, 48 ​​hours, 60 hours, 72 hours, etc., preferably 24 to 48 hours.

[0079] In one specific embodiment, in the preparation method of this application, in the step of preparing gel M, gel L is dialyzed in an alkaline or neutral buffer containing glutathione, then an ester or amide local anesthetic is added, then it is passed through a 50-70 mesh sieve, then filled into a syringe, and sterilized by moist heat at 115-125°C for 15-20 minutes to obtain the injectable adhesive sodium hyaluronate gel.

[0080] The "local anesthetic" in this application consists of three parts in its chemical structure: an aromatic ring, an intermediate chain, and an amine group. The intermediate chain can be an ester chain or an amide chain. Based on the structure of the intermediate chain, local anesthetics can be divided into two categories: the first category is ester-based local anesthetics, which have a -COO- group in their structure, and local anesthetics belonging to this category include procaine and tetracaine; the second category is amide-based local anesthetics, which have a -CONH- group in their structure, and local anesthetics belonging to this category include lidocaine and bupivacaine.

[0081] On the other hand, this application also provides an injectable adhesive sodium hyaluronate gel prepared by any of the preceding methods, which has the structure shown in formula (I).

[0082] In another aspect, this application also provides an injectable adhesive sodium hyaluronate gel, characterized in that it comprises a compound having the structure shown in formula (I).

[0083]

[0084] In one specific embodiment, the injectable adhesive sodium hyaluronate gel, wherein a is selected from 4 to 1117, for example, 4, 10, 44, 50, 100, 200, 250, 298, 300, 400, 500, 600, 700, 800, 900, 1000, 1110, 1117, etc., and b is selected from 4 to 1117, for example, 4, 10, 4 4, 50, 100, 200, 250, 298, 300, 400, 500, 600, 700, 800, 900, 1000, 1110, 1117, etc., where c is selected from 65 to 5211, for example, it can be 65, 100, 300, 600, 655, 1000, 1390, 2000, 3000, 4000, 5000, 5211, etc.

[0085] In one specific embodiment, the injectable adhesive sodium hyaluronate gel, wherein a is selected from 44 to 298, b is selected from 44 to 298, and c is selected from 655 to 1390.

[0086] In one specific embodiment, the injectable adhesive sodium hyaluronate gel is prepared using sodium hyaluronate with a molecular weight of 300-800 kDa.

[0087] In one specific embodiment, the injectable adhesive sodium hyaluronate gel is a mixture comprising two or more different compounds with structures shown in formula (I).

[0088] Using the preparation method of this application, the amount of crosslinking agent A can be increased by adjusting the molar ratio of cystine to 1,4-butanediol diglycidyl ether in step (1). The injectable adhesive sodium hyaluronate gel prepared by the method of this application has high adhesion. Using the adhesion characterization method described above, the time for the two glass slides to completely separate is more than 1 minute and 15 seconds, and can reach up to 2 minutes and 24 seconds. Furthermore, the adhesion of the gel product can be controlled by adjusting the type of crosslinking agent B, the molar ratio of crosslinking agent A to sodium hyaluronate repeating units, the molar ratio of crosslinking agent B to sodium hyaluronate repeating units, and the molar ratio of crosslinking agent A to crosslinking agent B.

[0089] The adhesive hyaluronic acid gel obtained in this application can not only be used for cosmetic filling, but can also be prepared by adjusting the composition, cross-linking method, and degree of cross-linking of hyaluronic acid to be used in fields such as medical aesthetics, tissue adhesion, drug loading, tissue engineering, and damage repair where tissue adhesion is required. By improving the tissue adhesion of the material, a more stable bond with the corresponding tissue can be achieved, which can effectively reduce the impact of movement on the displacement of the implanted material.

[0090] The present application will be described in detail below with reference to embodiments. However, it should be understood that the present application may be implemented in various forms and should not be limited to the embodiments set forth herein. Rather, these embodiments are provided so that this invention will be thorough and complete, and will fully convey the scope of the present application to those skilled in the art.

[0091] Example

[0092] Example 1

[0093] (1) 0.042 mol of cystine and 0.084 mol of 1,4-butanediol diglycidyl ether were mixed in 100 mL of 0.1 mol / L NaOH solution and stirred in a water bath at 20 °C for 8 hours. After separation and purification, 0.035 mol of epoxy crosslinking agent containing disulfide bonds was obtained.

[0094] (2) Dissolve 939.0g of sodium hyaluronate (molecular weight 800kDa, the amount of sodium hyaluronate repeating unit is 2.33mol) in 100mL of 1.5% NaOH solution and stir to dissolve to obtain sodium hyaluronate solution. Add crosslinking agent A and BDDE to the sodium hyaluronate solution and crosslink at 30℃ for 8 hours to obtain crosslinked gel L. The molar ratio of crosslinking agent A to BDDE is 0.5:1, and the molar ratio of the total amount of crosslinking agent A and BDDE to the amount of sodium hyaluronate repeating unit is 0.045:1.

[0095] (3) The gel L obtained in step (2) is mechanically broken and passed through a 60-mesh sieve to obtain particulate gel A;

[0096] (4) Dialyze particulate gel A with phosphate buffer containing 10 mmol glutathione at pH 8 for 6 hours to obtain gel M;

[0097] (5) Dialyze gel M with phosphate buffer at pH 7.4 for 24 hours to obtain gel N. Adjust the sodium hyaluronate content in gel N to 25 mg / mL, then pass it through a 60-mesh sieve, fill it into a syringe, and sterilize it at 121°C for 15 minutes to obtain an adhesive sodium hyaluronate gel for injection.

[0098] The adhesiveness of the sodium hyaluronate gel in this embodiment was characterized by measuring the time it took for the two glass slides to completely separate, as follows: Figure 1 As shown, a 25×25mm piece of fresh pigskin was fixed onto a 75×25mm glass slide, with the inside of the pigskin containing subcutaneous tissue facing outwards. 0.5mL of the prepared gel, prepared using this technique, was then evenly applied to the inner tissue of the pigskin. The two gel-loaded slides were overlapped and left to stand for 2 hours. A 5g weight was then applied, and a stopwatch was used to time the complete separation of the two slides. The separation time was 1 minute and 21 seconds. A longer separation time indicates higher adhesion.

[0099] Example 2

[0100] (1) 0.042 mol of cystine and 0.084 mol of 1,4-butanediol diglycidyl ether were mixed in 100 mL of 0.1 mol / L NaOH solution and stirred in a water bath at 10 °C for 8 hours. After separation and purification, 0.035 mol of epoxy crosslinking agent containing disulfide bonds was obtained.

[0101] (2) Dissolve 471.5g of sodium hyaluronate (molecular weight 300kDa, the amount of sodium hyaluronate repeating unit is 1.17mol) in 100mL of 1.5% NaOH solution, stir to dissolve, and obtain sodium hyaluronate solution. Add crosslinking agent A and BDDE to the sodium hyaluronate solution after mixing, and crosslink at 25℃ for 8 hours to obtain crosslinked gel L. The molar ratio of crosslinking agent A to BDDE is 1:1, and the molar ratio of the total amount of crosslinking agent A and BDDE to the amount of sodium hyaluronate repeating unit is 0.06:1.

[0102] (3) The gel L obtained in step (2) is mechanically broken and passed through a 60-mesh sieve to obtain particulate gel A;

[0103] (4) Dialyze the particulate gel A with a phosphate buffer containing 10 mmol glutathione at pH 8 for 6 hours to obtain the gel M;

[0104] (5) Dialyze the gel M with phosphate buffer at pH 7.4 for 24 hours to obtain gel N. Adjust the sodium hyaluronate content in gel N to 25 mg / mL, then pass it through a 60-mesh sieve, fill it into a syringe, and sterilize it at 121°C for 20 minutes to obtain an adhesive sodium hyaluronate gel for injection.

[0105] Referring to the adhesion characterization method in Example 1, the time for the two glass slides to completely separate was 2 minutes and 6 seconds.

[0106] Example 3

[0107] (1) 0.042 mol of cystine and 0.0966 mol of 1,4-butanediol diglycidyl ether were mixed in 100 mL of 0.1 mol / L NaOH solution and stirred in a water bath at 30 °C for 8 hours. After separation and purification, 0.039 mol of epoxy crosslinking agent A containing disulfide bonds was obtained. Since the molar ratio of cystine to BDDE is 1:2.3, the amount of crosslinking agent A obtained by separation and purification in this embodiment is higher than that in Example 1.

[0108] (2) Dissolve 1047.8g of sodium hyaluronate (molecular weight 800kDa, the amount of sodium hyaluronate repeating unit is 2.6mol) in 100mL of 1.5% NaOH solution, stir to dissolve, and obtain sodium hyaluronate solution. Add crosslinking agent A and BDDE to the sodium hyaluronate solution and react at 55℃ for 8 hours to obtain crosslinked gel L. The molar ratio of crosslinking agent A to BDDE is 0.5:1, and the molar ratio of the total amount of crosslinking agent A and BDDE to the amount of hyaluronic acid is 0.045:1.

[0109] (3) The gel L obtained in step (2) is mechanically broken and passed through a 60-mesh sieve to obtain particulate gel A;

[0110] (4) Dialyze the particulate gel A with a phosphate buffer containing 10 mmol glutathione at pH 8 for 6 hours to obtain the gel M;

[0111] (5) Dialyze the gel M with phosphate buffer at pH 7.4 for 12 hours to obtain gel N. Adjust the sodium hyaluronate content in gel N to 25 mg / mL, then pass it through a 60-mesh sieve, fill it into a syringe, and sterilize it at 121°C for 20 minutes to obtain an adhesive sodium hyaluronate gel for injection.

[0112] Referring to the adhesion characterization method in Example 1, the time for the two glass slides to completely separate was 1 minute and 20 seconds.

[0113] Example 4

[0114] (1) 0.021 mol of cystine and 0.084 mol of 1,4-butanediol diglycidyl ether were mixed in 100 mL of 0.1 mol / L NaOH solution and stirred in a water bath at 30 °C for 8 hours. After separation and purification, 0.004 mol of epoxy crosslinking agent A containing disulfide bonds was obtained. Since the molar ratio of cystine to BDDE is 1:4, the amount of crosslinking agent A obtained by separation and purification in this embodiment is extremely low.

[0115] (2) Dissolve 72.5g of sodium hyaluronate (molecular weight 800kDa, the amount of sodium hyaluronate repeating unit is 0.178mol) in 100mL of 1.5% NaOH solution, stir to dissolve, and obtain sodium hyaluronate solution. Add crosslinking agent A and BDDE to the sodium hyaluronate solution after mixing, and react at 55℃ for 8 hours to obtain crosslinked gel L. The molar ratio of crosslinking agent A to BDDE is 1:1, and the molar ratio of the total amount of crosslinking agent A and BDDE to the amount of sodium hyaluronate repeating unit is 0.045:1.

[0116] (3) The gel L obtained in step (2) is mechanically broken and passed through a 60-mesh sieve to obtain particulate gel A;

[0117] (4) Dialyze the particulate gel A with a phosphate buffer containing 10 mmol glutathione at pH 8 for 6 hours to obtain the gel M;

[0118] (5) Dialyze the gel M with phosphate buffer at pH 7.4 for 12 hours to obtain gel N. Adjust the sodium hyaluronate content in gel N to 25 mg / mL, then pass it through a 60-mesh sieve, fill it into a syringe, and sterilize it at 121°C for 20 minutes to obtain an adhesive sodium hyaluronate gel for injection.

[0119] Referring to the adhesion characterization method in Example 1, the time for the two glass slides to completely separate was 1 minute and 21 seconds.

[0120] Example 5

[0121] (1) 0.042 mol of cystine and 0.084 mol of 1,4-butanediol diglycidyl ether were mixed in 100 mL of 0.1 mol / L NaOH solution and stirred in a water bath at 30 °C for 8 hours. After separation and purification, 0.035 mol of epoxy crosslinking agent A containing disulfide bonds was obtained.

[0122] (2) Dissolve 939.0 g of sodium hyaluronate (molecular weight 800 kDa, the amount of substance of sodium hyaluronate repeating unit is 2.33 mol) in 100 mL of 1.5% NaOH solution, stir to dissolve, and obtain sodium hyaluronate solution. Then, add crosslinking agent A and crosslinking agent B... (n=11) After mixing, it is added to sodium hyaluronate solution and crosslinked at 55℃ for 8 hours to obtain crosslinked gel L, wherein the molar ratio of crosslinking agent A to crosslinking agent B is 0.5:1, and the molar ratio of the total amount of crosslinking agent A and crosslinking agent B to the amount of sodium hyaluronate is 0.045:1.

[0123] (3) The gel L obtained in step (2) is mechanically broken and passed through a 60-mesh sieve to obtain particulate gel A;

[0124] (4) Dialyze the particulate gel A with a phosphate buffer containing 10 mmol glutathione at pH 8 for 6 hours to obtain the gel M;

[0125] (5) Dialyze the gel M with phosphate buffer at pH 7.4 for 12 hours to obtain gel N. Adjust the sodium hyaluronate content in gel N to 25 mg / mL, then pass it through a 60-mesh sieve, fill it into a syringe, and sterilize it at 121°C for 20 minutes to obtain an adhesive sodium hyaluronate gel for injection.

[0126] Referring to the adhesion characterization method in Example 1, the time for the two glass slides to completely separate was 1 minute and 27 seconds.

[0127] Example 6

[0128] The difference between this embodiment and Embodiment 1 is that the amount of sodium hyaluronate repeating unit is 1.75 mol, the ratio of crosslinking agent A to BDDE is 1:1, and the ratio of the total amount of crosslinking agent A and BDDE to the amount of sodium hyaluronate repeating unit is 0.04:1.

[0129] Referring to the adhesion characterization method in Example 1, the time for the two glass slides to completely separate was 1 minute and 4 seconds.

[0130] Example 7

[0131] The difference between this embodiment and Embodiment 2 is that the amount of sodium hyaluronate repeating unit is 0.58 mol, the molar ratio of crosslinking agent A to BDDE is 2:1, and the molar ratio of the total amount of crosslinking agent A and BDDE to the amount of sodium hyaluronate repeating unit is 0.09:1. To ensure that all disulfide bonds are reduced to thiol groups, the dialysis time using phosphate buffer containing 10 mmol of glutathione at pH 8 needs to be extended to 48 hours.

[0132] Referring to the adhesion characterization method in Example 2, the time for the two glass slides to completely separate was 2 minutes and 17 seconds.

[0133] Example 8

[0134] The difference between this embodiment and Example 7 is that the molar ratio of crosslinking agent A to BDDE is 0.4:1, and the molar ratio of the total amount of crosslinking agent A and BDDE to the molar amount of sodium hyaluronate repeating unit is 0.21:1. To ensure that all disulfide bonds are reduced to thiol groups, the dialysis time using phosphate buffer containing 10 mmol of glutathione at pH 8 needs to be extended to 48 hours.

[0135] Referring to the adhesion characterization method in Example 7, the time for the two glass slides to completely separate was 2 minutes and 13 seconds.

[0136] Example 9

[0137] The difference between this embodiment and Example 7 is that the molar ratio of crosslinking agent A to BDDE is 0.4:1, and the molar ratio of the total amount of crosslinking agent A and BDDE to the molar amount of sodium hyaluronate repeating unit is 0.28:1. To ensure that all disulfide bonds are reduced to thiol groups, the dialysis time using phosphate buffer containing 10 mmol of glutathione at pH 8 needs to be extended to 48 hours.

[0138] Referring to the adhesion characterization method in Example 7, the time for the two glass slides to completely separate was 2 minutes and 24 seconds.

[0139] The parameters and effect data of Examples 1 to 9 are summarized in Table 1 below:

[0140] Table 1

[0141]

[0142] As can be seen from the data in Table 1, the molar ratio of crosslinking agent A to sodium hyaluronate repeating units has the greatest impact on the adhesion of sodium hyaluronate gel, while the molar ratio of crosslinking agent B to sodium hyaluronate repeating units has a relatively large impact on the adhesion of sodium hyaluronate gel. The molar ratio of crosslinking agent A to sodium hyaluronate repeating units in Example 2 is within the range of this application and is superior to Examples 1, 3, and 4. Therefore, the adhesion of Example 2 is significantly better than that of Examples 1, 3, 4, and 5. Compared with Example 4, the molar ratios of crosslinking agent A to sodium hyaluronate repeating units and crosslinking agent B to sodium hyaluronate repeating units in Example 6 are both smaller than those in Example 4. Therefore, the adhesion of Example 4 is superior to that of Example 6. For Examples 7-9, since the molar ratio of crosslinking agent A to sodium hyaluronate repeating unit in Examples 7-9 is significantly greater than that in other examples, and the molar ratio of crosslinking agent B to sodium hyaluronate repeating unit in Examples 8-9 is significantly greater than that in other examples, the adhesion of Examples 7-9 is slightly better than that of Example 2.

[0143] Comparative Example 1

[0144] (1) Dissolve 939.0g of sodium hyaluronate (molecular weight 800kDa, the amount of substance of sodium hyaluronate repeating unit is 2.33mol) in 80mL of aqueous solution. After stirring and dissolving completely, a sodium hyaluronate solution is obtained. Add 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) in the same amount as the carboxyl groups in the sodium hyaluronate molecule. Activate the reaction for 8 hours. Then add cystine and continue stirring for 8 hours to obtain a cross-linked gel. The molar ratio of cystine to sodium hyaluronate repeating unit is 0.035:1.

[0145] (2) Soak the crosslinked gel obtained in step (1) in 10L of deionized water 8 times, each time for 6 hours. After each soaking, replace the waste liquid with 10L of deionized water.

[0146] (3) The gel obtained in step (2) is broken by mechanical force and passed through a 60-mesh sieve to obtain a microparticle gel;

[0147] (4) Dialyze the particulate gel with a phosphate buffer containing 10 mmol glutathione at pH 8 for 6 hours. Since all the disulfide bonds in the cross-linking agent cystine are reduced to free sulfhydryl groups by glutathione, the particulate gel network disintegrates and becomes a solution.

[0148] This method cannot produce an adhesive sodium hyaluronate gel.

[0149] Comparative Example 2

[0150] (1) Dissolve 939.0g of sodium hyaluronate (molecular weight 800kDa, the amount of sodium hyaluronate repeating unit is 2.33mol) in 80mL of 1.5% NaOH solution, stir to dissolve, and obtain sodium hyaluronate solution. Add BDDE to sodium hyaluronate solution and crosslink at 30℃ for 8 hours to obtain crosslinked gel. The molar ratio of BDDE to sodium hyaluronate repeating unit is 0.07:1.

[0151] (2) The cross-linked gel obtained in step (1) is broken by mechanical force and passed through a 60-mesh sieve to obtain a particulate gel.

[0152] (3) Dialyze the particulate gel with phosphate buffer at pH 7.4 for 24 hours to adjust the sodium hyaluronate content in the particulate gel to 25 mg / mL;

[0153] (4) Pass the gel microparticles obtained in step (3) through a 60-mesh sieve, fill them into a syringe, and sterilize them at 121°C for 18 minutes to obtain sodium hyaluronate gel.

[0154] Referring to the adhesion characterization method in Example 1, the time for complete separation of the two glass slides was 9 seconds. The sodium hyaluronate gel prepared by this method has low adhesion.

[0155] Comparative Example 3

[0156] 939.0 g of sodium hyaluronate (molecular weight 800 kDa, molar amount of repeating unit of sodium hyaluronate is 2.33 mol) was dissolved in 100 mL of 1.5% NaOH solution and stirred until dissolved. 0.035 mol of cystine and 0.14 mol of BDDE were mixed and added to the sodium hyaluronate solution. The cross-linking reaction was carried out at 30 °C for 8 hours to obtain sodium hyaluronate gel.

[0157] Referring to the adhesion characterization method in Example 1, the time for the two glass slides to completely separate was 33 seconds.

[0158] In this method of preparing hyaluronic acid gel, the cross-linking agent BDDE reacts not only with sodium hyaluronate but also with cystine. However, the ratio of the two reactions cannot be guaranteed, and ultimately the amount of cystine introduced into the sodium hyaluronate gel cannot be guaranteed. Therefore, it cannot be guaranteed that thiol groups can be introduced into the sodium hyaluronate gel to give it adhesive properties.

[0159] Comparative Example 4

[0160] 939.0 g of sodium hyaluronate (molecular weight 800 kDa, molar amount of repeating unit of sodium hyaluronate is 2.33 mol) was dissolved in 100 mL of 1.5% NaOH solution and stirred until dissolved. 0.07 mol of cysteine ​​and 0.14 mol of BDDE were mixed and added to the sodium hyaluronate solution. The cross-linking reaction was carried out at 30 °C for 8 hours to obtain sodium hyaluronate gel.

[0161] In this method of preparing sodium hyaluronate gel, BDDE reacts not only with sodium hyaluronate during the reaction, but also with the amino and thiol groups in cysteine. On the one hand, the degree of cross-linking of the cross-linked gel cannot be determined. On the other hand, after BDDE reacts with the thiol groups in cysteine, an adhesive hyaluronic acid gel cannot be obtained.

[0162] The parameter data for comparative examples 1 to 4 are summarized in Table 2 below:

[0163] Table 2

[0164]

[0165] The above description is merely a preferred embodiment of this application and is not intended to limit the application in any other way. Any person skilled in the art may make changes or modifications to the disclosed technical content to create equivalent embodiments. However, any simple modifications, equivalent changes, and modifications made to the above embodiments based on the technical essence of this application without departing from the scope of the technical solution of this application shall still fall within the protection scope of this application.

Claims

1. A cross-linking agent, characterized in that Its structural formula is 2. Use of the cross-linking agent according to claim 1 in the preparation of an adhesive sodium hyaluronate gel for injection.

3. A gel intermediate, characterized in that: It includes compounds having the structure shown in the following formula:

4. The gel intermediate according to claim 3, characterized in that: a is 4~1117, b is 4~1117, and c is 65~5211.

5. The gel intermediate according to claim 4, characterized in that: a is 44~298, b is 45~298, and c is 655~1390.

6. Use of the gel intermediate according to any one of claims 3 to 5 in the preparation of an adhesive sodium hyaluronate gel for injection.